Glucometer is a
medical device that determines the approximate concentration of glucose in the
blood. It
typically uses a drop of blood which is placed on a disposable test strip where its chemical reaction with glucose changes the electrical conductivity of the strip. Some of the characteristics which defines the excellency of a
glucometer includes small size, computer downloading capabilities, extended
memory capacity and blood glucose manipulation techniques. True Metrix
Self-Monitoring Glucose System is known to be the best glucometer used across
the world because of its quick and accurate blood glucose testing. In the
growing field of medical devices, Israel is ranked at second position with a
total of thousand companies manufacturing a huge number of medical devices
every year. In the recent years, there has been a recognizable increase in
prevalence of various chronic diseases among population of Israel especially
cancer, cardiac disorders, and diabetes. Among all these diseases, there is no
permanent cure for diabetes. However, with treatment the condition can be managed,
and it is possible to reach a stage of diabetes remission. Several devices that
can assist patients to manage their diabetes comprises of ketone monitor, blood
glucose monitor, continuous glucose monitor, insulin pumps, smart insulin pens,
and diabetes management applications. Increase in number of treatment
procedures carried out in the country due to rise in diabetes instances is
leading to rise in purchase of glucometers which is expected to boost the
growth of Israel glucometer market in upcoming years. Moreover, high obesity
rate among people of the country, which is one of the major risk factors
related to diabetes, can also propel the growth of glucometer market in Israel.
Growing technological advancements associated with improvement in healthcare
facilities of the country is also expected to bolster the growth of glucometer
market in Israel. Henceforth, growth in geriatric population of the country is
also expected to propel the growth of market in coming years due to their
increasing chances of getting affected with various kinds of diseases.
Growing
Prevalence of Chronic Diseases
Chronic disease
can be defined as a long-term health condition that persist over a prolonged
period and may require ongoing medical attention or management. These diseases
are typically non-communicable diseases and are caused by a combination of
genetic, environmental, and lifestyle factors. Some of the commonly prevailing
diseases among the people of Israel comprises of cancer, cardiac disorders, and
diabetes. As per Israel Diabetes Market Report 2023, Type 1 diabetes holds
minimum percentages among Israelis than Type 2 diabetes mellitus. Some of the
common risk factors which lead to the development of diabetes in a human body
comprises of intake of unhealthy diet, physical inactivity, consumption of
alcohol, smoking cigarettes, and others. According to the data published by
National Library of Medicine in 2019, it has been reported that out of the
total sample population, 13.7% were found to be affected with Type 2 Diabetes
Mellitus (T2DM). The prevalence of T2DM increased sharply over successive age
groups in both men and women. The prevalence of type 2 diabetes has been found
to increase gradually with increasing BMI, especially in women (~20%, 37%, and
44%, respectively), while, in men it increased sharply (from 25% to ~50%) until
a BMI of 29.9; it then decreased drastically (to ~24%) for a BMI of ≥30.
Approximately 85% of men with type 2 diabetes were physically inactive, while
her 97% of women with type 2 diabetes were physically inactive. According to Food and Drug Administration
(FDA), it has been observed that accurate glucometers provide result within 15%
of the lab reading. The evident increase in prevalence of diabetes among
Israelis is leading to the rise in demand of glucometers by patients which is expected
to propel the growth of Israel Glucometer market in the forecast period.
Download Free Sample Report
Technological
Advancements
Increasing
prevalence of diabetes in Israel is leading to various technological
advancements in the healthcare system of the country. Combo Glucometer (CoG) is
the first non-invasive product which has been made commercial in the country
that can be used for glucose monitoring. While using Combo Glucometer, the user
only needs to place a finger in the device, which assesses reflected light from
tissue via a digital image sensor and then employs proprietary algorithms to
measure blood glucose levels. Moreover, GlucoTrack is another device developed
by U.S.–Israeli company which can monitor blood sugar levels through a
combination of ultrasonic, electromagnetic, and thermal waves. Better and more
accurate diabetic care in healthcare centers is assisting patients, which is expected
to bolster the growth of Israel glucometer market in the forecast period.
Rise in
Geriatric Population
Among several
chronic diseases, diabetes is the most common disease which is found to be
highly prevailing among geriatric population of Israel. According to a
survey, it has been observed that in 2018, 11.8% of the total population which
accounted for 1,056,300 people were at either 65 years of age or above. Around
55.5% of them were women and rest 44.5 % were men. In
the same year, 41% of senior citizens were 75 years of age. Development of
risk factors such as physical inactivity and lack of nutrients in diet are the
main risk factors which are leading to rise in instances of diabetes among
elder people. Growing demand of devices such as glucometer by people to monitor
their blood sugar level on regular basis for management of diabetes is likely
to propel the growth of glucometer market in Israel during the futuristic
period.
Growing
Prevalence of Obesity
The
accumulation of an excessive amount of body fat can cause diabetes, and the
risk of type 2 diabetes increases linearly with an increase in body mass index.
Obesity is one of the leading risk factors among Israelis which is reported to
be the major reason behind wide spread of diabetes across various regions of
the country. According to
the report published by Jewish News Syndicate (JNS) in 2023, it was found that
55% of men and 41% of women are overweight. A new study released by Israel’s
Central Bureau of Statistics revealed that approximately half of Israelis over
the age of 20 are overweight. Moreover, 54 percent of Arabs were found to be
overweight, as compared to 46 percent of Jews. Growing prevalence of
diabetes among people of Israel due to rise in consumption of unhealthy food is
expected to boost the growth of glucometer market in upcoming years.
Recent
Developments
- In
August 2021, HAGAR, an Israeli health technology company and developer of GWave,
the world's first non-invasive continuous blood glucose monitoring system that
uses RF waves to measure blood glucose levels, received an investment of USD
17.1 million from Columbia Pacific. The funds will be used to complete his
upcoming FDA-approved clinical trials and international patents.
- In
October 2022, Dexcom introduced the Dexcom G7, a next-generation continuous
glucose monitor (CGM), for diabetics two years of age and above. Dexcom G7 made
an improvement on Dexcom continuous glucose monitoring (CGM) by adding new
features such as 60% smaller and discreet all-in-one wearable than any other
CGM on the market, with the fastest 30-minute sensor warm-up.
- In
June 2020, Tandem Diabetes Care and Abbott announced a collaboration to develop
and commercialize an integrated solution for diabetes care. These products
combine Abbott's continuous glucose monitoring technology with Tandem's
breakthrough insulin delivery device to improve glycemic control in diabetics.
Israel glucometer market is
segmented based on product type, technique, type, distribution channel, end
source, company, and region. In terms of product type, the glucometer market is
categorized into self glucose monitoring glucometers and continuous glucose
monitoring glucometers. Based on, technique, market is divided into invasive
and non-invasive. On the basis of type, glucometer market is segmented into
wearable and non-wearable. Based on distribution channel, the market is fragmented
into hospital pharmacies, retail outlet, online, and others. Based on end user,
the glucometer market is segmented into hospitals & clinics, diagnostic
centers, home care, and others.
Market Players
Cnoga Medical Ltd., F.
Hoffmann-La Roche AG, Medtronic, Inc., Dexcom, Inc., DarioHealth Crop., Tandem
Diabetes Care, Inc., Abbott Laboratories, and Dreamed Diabetes Ltd.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024-2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume in Tons and
CAGR for 2018-2022 and 2023-2028
|
|
Report Coverage
|
Revenue
forecast, volume forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments Covered
|
Product Type
Technique
Type
Distribution Channel
End User
|
|
Regional Scope
|
The
Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, and The
Negev Desert
|
|
Key Companies Profiled
|
Cnoga Medical Ltd., F. Hoffmann-La
Roche AG, Medtronic, Inc., Dexcom, Inc., DarioHealth Crop., Tandem Diabetes
Care, Inc., Abbott Laboratories, and Dreamed Diabetes Ltd.
|
|
Customization Scope
|
10% free report
customization with purchase. Addition or alteration to country, regional
& segment scope.
|
|
Pricing and Purchase Options
|
Avail customized purchase options to
meet your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email (We can
also provide the editable version of the report in PPT/Word format on special
request)
|
Report Scope:
In this report, Israel glucometer market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
·
Israel
Glucometer Market, By Product Type:
o
Self-Glucose Monitoring
Glucometers
o
Continuous Glucose Monitoring
Glucometers
·
Israel
Glucometer Market, By Technique:
o
Invasive
o
Non-Invasive
·
Israel
Glucometer Market, By Type:
o
Wearable
o
Non-Wearable
·
Israel
Glucometer Market, By Distribution Channel:
o
Hospital Pharmacies
o
Retail Outlet
o
Online
o
Others
·
Israel
Glucometer Market, By End User:
o
Hospitals & Clinics
o
Diagnostic Centers
o
Home Care
o
Others
Competitive Landscape
Company Profiles: Detailed analysis
of the major companies present in Israel glucometer market.
Available
Customizations:
With
the given market data, TechSci Research offers customizations according to a
company’s specific needs. The following customization options are available for
the report:
Company
Information
- Detailed analysis and profiling of
additional market players (up to five).
Israel
glucometer market is an upcoming report to be released soon. If you wish an
early delivery of this report or want to confirm the date of release, please
contact us at [email protected]